Low level of plasminogen increases risk for mortality in COVID-19 patients
David Della‐Morte(Unknown), Nicola Di Daniele(University of Rome Tor Vergata), Stefano Bonassi(San Raffaele University of Rome), Renato Massoud(University of Rome Tor Vergata), Davide Lauro(University of Rome Tor Vergata), Valentina Rovella(University of Rome Tor Vergata), Mariannina Iozzo(University of Rome Tor Vergata), Francesca Pacifici(University of Rome Tor Vergata), Sergio Bernardini(University of Rome Tor Vergata), Stefania Proietti(San Raffaele University of Rome), Camillo Ricordi(Miami Transplant Institute)
Cited by 36
Related Papers
HUMN project: detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2002|1.4k
An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans
|Carcinogenesis|2006|1k
Buccal micronucleus cytome assay
|Nature Protocols|2009|635
The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: The HUMN project perspective on current status and knowledge gaps
|Mutation Research/Reviews in Mutation Research|2008|596
Islet isolation assessment in man and large animals
|Acta Diabetologica|1990|581